All Stories

  1. Hipoglucemias severas recurrentes en una mujer posmenopáusica no diabética: reporte de caso
  2. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
  3. Cefepime-Induced Neurotoxicity in an Elderly Patient: A Case Report
  4. impacto al medio ambiente de los aparatos electrónicos
  5. Prevalencia de anemia en pacientes con enfermedad renal crónica en estadio 4 y evaluación de eventos cardiovasculares
  6. Overcoming the Hurdle: HLA Mismatch and Desensitization Therapy in Kidney Transplantation
  7. Membranous nephropathy: genetics, antigens and antibodies
  8. Nefropatía membranosa: genética, antígenos y anticuerpos
  9. WCN24-2020 KIDNEY STONES IN HOT CLIMATES: INCIDENCE AND TREATMENT COSTS
  10. WCN24-2194 EVALUATION OF ANEMIA IN PATIENTS REFERRED BY PRIMARY CARE PHYSICIANS TO NEPHROLOGY
  11. Kidney biopsies among persons living in hotspots of CKDu: a position statement from the International Society of Nephrology’s Consortium of Collaborators on CKDu
  12. Acute Presentation of Mesoamerican Nephropathy in an Agricultural Worker From Panama
  13. Vaccination and mortality from COVID-19: a comparative study between hemodialysis, peritoneal dialysis, and non-dialysis adult population in Panama
  14. Overcoming obstacles in Panama to starting a renal biopsy program in a rural area during the COVID-19 pandemic
  15. Chronic kidney disease of nontraditional causes in central Panama
  16. Anemia in chronic kidney disease
  17. Mesoamerican Nephropathy in Central Panama
  18. Proceso de desensibilización ANTI-HLA en receptores de donante vivo HLA Clase II incompatible con anticuerpos donante específico
  19. Efectos de la infección por COVID-19 en pacientes renales. Encuesta Latinoamericana ACECANH 2020
  20. Cytokine Removal and Immunomodulation in COVID-19 Severe Pulmonary Respiratory Infection
  21. La diálisis peritoneal en Centroamérica y el Caribe: estado actual, necesidades y propuestas
  22. Consenso del Grupo Centroamericano y del Caribe para el Estudio y Tratamiento de la Enfermedad de Fabry